RegenerativeTreatment Guide
  • Conditions
  • Locations
  • How It Works
  • About
  • Blog
  • For Providers
  • Cost Calculator
  • Free Assessment
(888) 540-7505
Editorial & Medical Review

Who Writes & Reviews Our Content

Trustworthy health information starts with knowing who's behind it. Here's our team, our review process, and our commitment to evidence-based accuracy.

Last updated November 18, 2026

Trustworthy health information depends on transparency — about who produces it, what sources it rests on, and how it is checked. This page explains exactly that. Regenerative Treatment Guide publishes patient education about stem cell and regenerative medicine for people exploring non-surgical options for knee, back, shoulder, hip, and joint pain. Below is who writes and reviews that content, the standards we hold it to, and how we handle the very real uncertainty in this field.

Our editorial team

RTG

Regenerative Treatment Guide Editorial Team

Health writers & researchers

Our editorial team researches and writes plain-English explanations of regenerative medicine, drawing on peer-reviewed literature, clinical-trial registries, and regulatory guidance. We focus on helping patients understand non-surgical options — and on clearly separating established science from areas that are still investigational. We do not provide medical care, and nothing we publish is a substitute for a consultation with a licensed physician.

Medical review

Dr. Long Vu, DO, MS, D.ABA

Long Vu, DO, MS, D.ABA (“Dr. Long”)

Medical Reviewer · Anesthesiology & Pain Medicine

Dr. Long Vu, who goes by Dr. Long, is an osteopathic physician board-certified by the American Board of Anesthesiology in anesthesiology and in pain medicine. He earned his DO at the Chicago College of Osteopathic Medicine of Midwestern University in 2000 and completed his anesthesiology residency at Beth Israel Deaconess Medical Center, a Harvard Medical School teaching hospital. He has practiced interventional pain medicine for more than 20 years, is licensed in Colorado and Florida, and now practices regenerative and longevity medicine at thriveMD in Centennial, Colorado. For Regenerative Treatment Guide, he reviews patient-education content for clinical accuracy, FDA-status language, and how risks and limitations are described.

Disclosure: Dr. Long practices at thriveMD, a clinic in our partner network that receives patient referrals through this site. He is not paid by Regenerative Treatment Guide for his reviews, and he may decline to approve any article. He does not review our Colorado page, our Approved Providers directory, or any content that names or compares thriveMD.

Verify: NPI 1194723973 · Florida license OS9477 · Colorado license DR.0057244 · ABA certification · Doximity

Review status: No articles carry Dr. Long's review yet. As he reviews each page, it will show a "Medically reviewed by" line with the date of his review. We never add a reviewer's name to a page he has not read. Our dog and veterinary content does not have a veterinary reviewer yet, and we are continuing to add reviewers.

The standard our reviewers are held to

A medical reviewer's job is not to rubber-stamp content. Before an article carries a "medically reviewed" label, the reviewer is asked to confirm that:

  • Every clinical claim is supported by a credible source and is stated with appropriate caution.
  • Established science is clearly distinguished from investigational or unproven uses.
  • Regulatory status (including FDA approval status) is described accurately.
  • No language implies a guaranteed outcome, cure, or result.
  • Risks, limitations, and the importance of an individual physician evaluation are stated plainly.

Our editorial standards & sourcing hierarchy

Not all sources are equal. When we research a topic, we prioritize evidence in roughly this order:

  • Peer-reviewed research and systematic reviews indexed in PubMed — the strongest basis for a clinical claim.
  • Registered clinical trials on ClinicalTrials.gov, which show what is actively being studied.
  • Government and regulatory guidance from the FDA and NIH.
  • Professional and academic society resources for context and consensus.

We do not treat clinic marketing material, testimonials, or anecdotal claims as evidence. When a topic is genuinely uncertain, we say so rather than overstating it.

How we handle uncertainty

Regenerative medicine is an area where marketing often runs ahead of the science, so we are deliberate about uncertainty. For example, the FDA states that stem cell and exosome products have not been approved for orthopedic uses, and that there are currently no approved exosome products. The approved stem cell products are cord-blood-derived, blood-forming cells for blood disorders and a few products for blood cancers and transplant complications, such as Ryoncil (December 2024). Regenerative products such as stem cells, exosomes, adipose-derived products, Wharton's jelly, cord blood, and amniotic fluid have not been approved to treat orthopedic conditions like osteoarthritis, tendonitis, disc disease, or back, hip, knee, neck, and shoulder pain. Where the research is promising but not conclusive — as with mesenchymal stem cells for knee osteoarthritis — we describe it as promising and investigational, not proven.

How our review process works

  • Articles are researched against peer-reviewed sources and clinical-trial registries.
  • Every significant medical claim is linked to a primary or authoritative source.
  • Content carries clear disclaimers and "last updated / last reviewed" dates.
  • Our medical reviewer receives each article as a review packet listing every clinical claim and its source. He can approve it, request changes, or decline. Only an approved version carries his name, and every review is logged with its date.

Corrections & updates policy

Medicine evolves, and so should our content. We review key articles periodically and update them when guidance, evidence, or regulatory status changes — noting the "last updated" date when we do. If you spot something you believe is inaccurate or out of date, we want to know. We investigate every good-faith report and correct confirmed errors promptly.

How to contact us about content

Questions, corrections, or concerns about anything we publish can be sent to [email protected]. Learn more about our methodology on the Our Approach to Research & Patient Guidance page.

Our content is educational and not a substitute for professional medical advice. Many regenerative uses are investigational and not FDA-approved. Always consult a qualified, licensed healthcare provider about your specific situation.

Medical Disclaimer

The information provided on this website is for educational purposes only and is not intended as medical advice, diagnosis, or treatment. Stem cell therapy results vary by patient and are not guaranteed. Many uses are investigational and not FDA-approved. Always consult with a qualified healthcare provider to discuss your specific medical situation and treatment options.


© 2026 Regenerative Treatment Guide. All rights reserved.

Talk to a clinic: (888) 540-7505 · Mon–Sat 8am–6pm ET

  • About Us
  • Our Approach
  • Editorial Team
  • Conditions
  • Regenerative Medicine for Dogs
  • Locations
  • Blog
  • Approved Providers
  • Podcast
  • FDA & Safety
  • FDA Warning Letters
  • Cost Calculator
  • Privacy Policy
  • Terms of Service
  • Facebook
  • YouTube
  • LinkedIn